Flow cytometry analysis of the clinical GBM samples was further performed to assess the frequency of ETV2+ CD31+ cells located in either the tumor margin or deeper regions (3–5 cm from the margin) of the GBM samples. This evidence concerns the gene ETV2 and neoplasm.